Cavendish Impact Capital
Edit

Cavendish Impact Capital

http://www.cavendishfoundation.org
Last activity: 09.08.2022
Active
Invests in categories: BioTechDataDevelopmentDrugHardwareHealthTechHumanMedTechPlatformTechnology
CIF is a 501(c)(3) organization that aggregates philanthropic capital and uses it for venture capital-class impact investing in early-stage health and life science companies focused on high unmet medical need.
News
10
Portfolio
44
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 44

DateNameWebsiteTotal RaisedLocation
07.07.2022Origami Th...origamitherapeutics.com-United Sta...
05.04.2022Bicara The...bicara.com$635M-
17.03.2022Rejuvenati...rejuvenationtech.com$10.6MUnited Sta...
17.02.2022OCON Healt...oconmed.com$10MIsrael, Ce...
17.02.2022Sonavi Lab...sonavilabs.com$1MUnited Sta...
04.02.2022AOAaoadx.com$26.5MUnited Sta...
04.10.2021Beckley Ps...beckleypsytech.com$99.12MUnited Kin...
04.10.2021Cellevolvecellevolve.com-United Sta...
03.09.2021Sanasana.io-United Kin...
29.06.2021Lyndra The...lyndra.com$252.5MUnited Sta...
Show more

News 10

DateTitleDescription
19.05.2021Microbion's Pravibismane, Potential New Antimicrobial Class, Gets 2nd CFF Grant-
20.03.2021X-Therma is Awarded for NSF Grants Continuously!-
20.03.2021EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19-
16.12.2020Big Rock Partners Acquisition Corp. Announces Merger with CIF Portfolio Company NeuroRx, Inc.-
24.11.2020NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure-
24.11.2020ISRAEL21c: One new drug may treat both Covid-19 and Alzheimer’s (Copy)CIF portfolio company AZTherapies announced on November 18th that their Alzheimer’s treatment, ALZT-OP1, has completed its COGNITE Phase 3 clinical trial and that they plan on sharing the COGNITE top-line clinical results in the first quart...
24.06.2020ISRAEL21c: One new drug may treat both Covid-19 and Alzheimer’s-
30.04.2020Behind the Bell: Applied Therapeutics-
10.02.2020Stanford Medicine: Brain-wave pattern can identify people likely to respond to antidepressant, study finds-
27.01.2020PR Newswire: StemoniX's microBrain® to be Featured in Podium Presentation at SLAS 2020 International Conference & Exhibition-

Reviews 0

Sign up to leave a review

Sign up Log In